Related Experiment Video
Updated: Jun 20, 2026

Assays for the Specific Growth Rate and Cell-binding Ability of Rotavirus
Published on: January 28, 2019
Finland introduces rotavirus vaccine into the national vaccination programme in September 2009
1Department of Vaccines and Immune Protection, National Institute of Health and Welfare, Helsinki, Finland. hanna.nohynek@thl.fi
Abstract:
Supported by an economic evaluation, rotavirus vaccine is introduced into the national immunisation schedule in Finland. The vaccination programme has been estimated to be reasonably cost-effective. Given at the age of two, three and five months, the vaccine is expected to prevent annually in Finland among children under the age of five years approximately 2,000 rotavirus diarrhoea episodes needing hospitalisation, and over 10,000 outpatient visits. The impact of the programme will be evaluated in 2011 by repeating the economic analysis and carefully monitoring adverse events.
Related Concept Videos
Respiratory Syncytial Virus Disease
Poliomyelitis
Vaccinations
Influenza
Bacterial Gastroenteritis
